These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31694137)
1. [Gastroenteropancreatic neuroendocrine tumor microenvironment and related therapy]. Ye C; Yuan CH; Li G; Zheng L; Xiu DR Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):866-871. PubMed ID: 31694137 [TBL] [Abstract][Full Text] [Related]
2. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research]. Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related]
5. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement. Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895 [TBL] [Abstract][Full Text] [Related]
6. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges. Garcia-Carbonero R Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057 [No Abstract] [Full Text] [Related]
7. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study. Zhang X; Ma L; Bao H; Zhang J; Wang Z; Gong P BMC Endocr Disord; 2014 Jul; 14():54. PubMed ID: 25001493 [TBL] [Abstract][Full Text] [Related]
8. [Gastroenteropancreatic neuroendocrine tumors : (GEP-NENs)]. Sebesta C; Feichter A; Selimi F Wien Med Wochenschr; 2023 Jun; 173(9-10):221-226. PubMed ID: 36512264 [TBL] [Abstract][Full Text] [Related]
9. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors. Phan AT; Kunz PL; Reidy-Lagunes DL Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956 [TBL] [Abstract][Full Text] [Related]
10. The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors. Cloyd JM; Konda B; Shah MH; Pawlik TM Expert Rev Clin Pharmacol; 2019 Feb; 12(2):101-108. PubMed ID: 30582383 [TBL] [Abstract][Full Text] [Related]
15. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)]. Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1305-1329. PubMed ID: 36575783 [TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
17. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract. Cives M; Strosberg J Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921 [TBL] [Abstract][Full Text] [Related]
18. Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors. Du S; Ni J; Weng L; Ma F; Li S; Wang W; Sang X; Lu X; Zhong S; Mao Y Medicine (Baltimore); 2015 Aug; 94(34):e1429. PubMed ID: 26313798 [TBL] [Abstract][Full Text] [Related]